Skip to content

Artificial Intelligence-Based Cognitive Training in Patients With Stroke

Effect of Artificial Intelligence-Based Training on Cognitive Functions in Patients With Stroke

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT07452276
Acronym
AICoRe-Stroke
Enrollment
40
Registered
2026-03-05
Start date
2026-01-01
Completion date
2026-06-06
Last updated
2026-03-05

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Artifical Intelligence, Post-Stroke Cognitive Impairment (PSCI), Stroke

Brief summary

This study would answer the following question:Does AI application-based training improve cognitive function in Patients with Stroke? The aims of this study: To investigate the efficacy of AI application-based training on cognitive function in stroke patients.

Interventions

DEVICEcognifit Mobile Application for Cognitive Training

A structured artificial intelligence-based cognitive training program targeting attention, memory, executive function, and processing speed in patients with stroke. The program provides adaptive, individualized exercises based on participant performance.

A structured conventional rehabilitation program consisting of aerobic exercises, relaxation exercises, and traditional paper-based cognitive exercises for patients with stroke. The duration and frequency of treatment are matched to the experimental group.

Sponsors

Omima Alaa Eldin Hussein
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
DOUBLE (Subject, Caregiver)

Eligibility

Sex/Gender
ALL
Age
45 Years to 60 Years
Healthy volunteers
No

Inclusion criteria

* Patient's age will range from 45- 60 years. * Diagnosis of stroke in the chronic stage (≥3 months post-onset). * Presence of cognitive impairment confirmed by a Montreal Cognitive Assessment (MoCA) score ≤ 26. * Medically stable and able to follow instructions. * patients with memory deficits following stroke

Exclusion criteria

\- Patients will be excluded if they have: * Severe visual, hearing, or speech impairments prevent participation. * History of other neurological or psychiatric disorders. * Unstable cardiovascular or systemic disease. * Severe depression (Beck Depression Inventory \> 29).

Design outcomes

Primary

MeasureTime frameDescription
Change in Cognitive FunctionBaseline and 6 weeks post-interventionChange in Global Cognitive Function Measured by the Montreal Cognitive Assessment (MoCA) Global cognitive function will be assessed using the Montreal Cognitive Assessment (MoCA), a one-page, 30-point cognitive screening tool that evaluates attention, memory, executive function, language, visuospatial abilities, abstraction, calculation, and orientation. The test takes approximately 10 minutes to administer. Scores range from 0 to 30, with higher scores indicating better cognitive function. A score of less than 26 indicates cognitive impairment.

Countries

Egypt

Contacts

CONTACTOmima Alaa Eldin Hussein
omimaalaa27@gmail.com+201207838324

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Mar 6, 2026